DarioHealth Corp. (DRIO) stock
DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15−0.11 (-8.73%)
Close on Nov 16, 2026Market cap $11.27MP/E 0.3Yield –
DarioHealth profit margin
Profit margin (net margin) is net income as a percentage of revenue.
DarioHealth's profit margin for the twelve months ending Jun 30, 2026 was -169.9%. For fiscal 2025 it was -186.6%, against -158.1% the year before. The highest annual figure on record is -158.1% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -186.6% | −28.5 |
| FY2024 | Dec 31, 2024 | -158.1% | +133.9 |
| FY2023 | Dec 31, 2023 | -292.0% | −67.1 |
| FY2022 | Dec 31, 2022 | -224.9% | +149.3 |
| FY2021 | Dec 31, 2021 | -374.2% | +14.5 |
| FY2020 | Dec 31, 2020 | -388.7% | −154.0 |
| FY2019 | Dec 31, 2019 | -234.6% | +6.1 |
| FY2018 | Dec 31, 2018 | -240.8% | +63.7 |
| FY2017 | Dec 31, 2017 | -304.5% | +83.9 |
| FY2016 | Dec 31, 2016 | -388.4% | +479.4 |
| FY2015 | Dec 31, 2015 | -867.8% | +24381.2 |
| FY2014 | Dec 31, 2014 | -25249.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -153.1% | +88.9 |
| Q1 FY2026 | Mar 31, 2026 | -147.7% | −11.1 |
| Q4 FY2025 | Dec 31, 2025 | -172.6% | −46.0 |
| Q3 FY2025 | Sep 30, 2025 | -209.0% | −42.9 |
| Q2 FY2025 | Jun 30, 2025 | -241.9% | −24.4 |
| Q1 FY2025 | Mar 31, 2025 | -136.7% | −12.0 |
| Q4 FY2024 | Dec 31, 2024 | -126.7% | +268.4 |
| Q3 FY2024 | Sep 30, 2024 | -166.1% | +281.1 |
| Q2 FY2024 | Jun 30, 2024 | -217.6% | +52.0 |
| Q1 FY2024 | Mar 31, 2024 | -124.6% | +56.9 |
| Q4 FY2023 | Dec 31, 2023 | -395.0% | −209.8 |
| Q3 FY2023 | Sep 30, 2023 | -447.2% | −210.5 |
| Q2 FY2023 | Jun 30, 2023 | -269.6% | +22.0 |
| Q1 FY2023 | Mar 31, 2023 | -181.5% | +16.0 |
| Q4 FY2022 | Dec 31, 2022 | -185.3% | +172.8 |
| Q3 FY2022 | Sep 30, 2022 | -236.7% | +162.1 |
| Q2 FY2022 | Jun 30, 2022 | -291.6% | +46.1 |
| Q1 FY2022 | Mar 31, 2022 | -197.5% | +218.8 |
| Q4 FY2021 | Dec 31, 2021 | -358.1% | +74.5 |
| Q3 FY2021 | Sep 30, 2021 | -398.7% | −78.0 |
| Q2 FY2021 | Jun 30, 2021 | -337.7% | −113.5 |
| Q1 FY2021 | Mar 31, 2021 | -416.3% | +177.1 |
| Q4 FY2020 | Dec 31, 2020 | -432.5% | −200.5 |
| Q3 FY2020 | Sep 30, 2020 | -320.8% | −170.6 |
| Q2 FY2020 | Jun 30, 2020 | -224.2% | +101.8 |
| Q1 FY2020 | Mar 31, 2020 | -593.4% | −353.6 |
| Q4 FY2019 | Dec 31, 2019 | -232.1% | +61.0 |
| Q3 FY2019 | Sep 30, 2019 | -150.2% | +66.1 |
| Q2 FY2019 | Jun 30, 2019 | -326.0% | −42.4 |
| Q1 FY2019 | Mar 31, 2019 | -239.8% | −73.6 |
| Q4 FY2018 | Dec 31, 2018 | -293.1% | −86.2 |
| Q3 FY2018 | Sep 30, 2018 | -216.2% | −0.0 |
| Q2 FY2018 | Jun 30, 2018 | -283.5% | +54.6 |
| Q1 FY2018 | Mar 31, 2018 | -166.2% | +371.3 |
| Q4 FY2017 | Dec 31, 2017 | -206.9% | +253.8 |
| Q3 FY2017 | Sep 30, 2017 | -216.2% | −132.3 |
| Q2 FY2017 | Jun 30, 2017 | -338.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -537.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -460.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -83.9% | – |
See a number that looks wrong?